Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 3/20 | 0.53 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.50 |
| ▸ | RAB9A | P51151 | 6/20 | 0.48 |
| ▸ | NPC1 | O15118 | 5/20 | 0.48 |
| ▸ | MAPT | P10636 | 4/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.48 |
| ▸ | ATM | Q13315 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | AVPR1A | P37288 | 3/20 | 0.42 |
| ▸ | AVPR2 | P30518 | 2/20 | 0.42 |
| ▸ | OXTR | P30559 | 2/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.42 |
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL541634 | 0.88 | MAPT (0.55) | HTTHDAC4RAB9ANPC1MAPT | |
| SCHEMBL14277962 | 0.84 | RAB9A (0.49) | HTTHDAC4RAB9ANPC1MAPT | |
| SCHEMBL5963053 | 0.80 | HTT (0.49) | HTTHDAC4RAB9ANPC1MAPT | |
| SCHEMBL12422701 | 0.79 | HTT (0.59) | HTTHDAC4RAB9ANPC1MAPT | |
| SCHEMBL18725064 | 0.78 | HTT (0.58) | HTTHDAC4RAB9ANPC1MAPT | |
| SCHEMBL16573989 | 0.78 | RAB9A (0.49) | RAB9ANPC1MAPTSMN1; SMN2L3MBTL1 | |
| SCHEMBL19366240 | 0.76 | HDAC4 (0.64) | HTTHDAC4RAB9ANPC1MAPT | |
| SCHEMBL2615994 | 0.76 | HTT (0.56) | HTTHDAC4RAB9ANPC1MAPT | |
| SCHEMBL5544146 | 0.76 | HTT (0.56) | HTTHDAC4RAB9ANPC1MAPT | |
| SCHEMBL5539090 | 0.76 | HTT (0.56) | HTTHDAC4RAB9ANPC1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-100497358-C | Iridium compound and organic electroluminescent device using the same | SAMSUNG SDI CO LTD (KR) | 2009-06-10 | — | — | CN | disclosed |
| US-7332233-B2 | Iridium compound and organic electroluminescent device using the same | SAMSUNG SDI CO., LTD. (KR) | 2008-02-19 | — | — | US | disclosed |
| US-7332233-B2 | Iridium compound and organic electroluminescent device using the same | SAMSUNG SDI CO., LTD. (KR) | 2008-02-19 | — | — | US | disclosed |
| US-7332233-B2 | Iridium compound and organic electroluminescent device using the same | SAMSUNG SDI CO., LTD. (KR) | 2008-02-19 | — | — | US | disclosed |
| CN-1626540-A | Iridium compound and organic electroluminescent device using the same | SAMSUNG SDI CO LTD (KR) | 2005-06-15 | — | — | CN | disclosed |
| US-20050031903-A1 | Iridium compound and organic electroluminescent device using the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2005-02-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050031903-A1 | Iridium compound and organic electroluminescent device using the same | IK, ALPL, PPIP5K2 | HTT 3044/4885HDAC4 2388/4885RAB9A 1790/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.